SURFACE ONCOLOGY, INC.: cash_and_equivalents
| Value | {"amount": 38523000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2019-09-30) |
| Status | current |
| Entity | SURFACE ONCOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:34:34.398132+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a7e7c11f-d144-4e61-8820-85b776a2fa1b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-042483Retrieved: 2026-08-19T17:34:34.398132+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001718108/cash-and-equivalents/2019-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a7e7c11f-d144-4e61-8820-85b776a2fa1b
History
- no predecessors — first report